We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current RASP market cap is 3.09M. The company's latest EPS is USD -0.0058 and P/E is 0.00.
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -915k | -5.43M | -248k | -384k | -4.24M |
Net Income | -936k | -5.35M | -785k | -687k | -4.44M |
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 4.95M | 33k | 45k | 85k | 96k |
Total Liabilities | 2.41M | 2.71M | 2.71M | 1.77M | 2.05M |
Total Equity | 2.54M | -2.68M | -2.66M | -1.69M | -1.96M |
Year End 30 September 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -93k | -251k | -293k | -313k | -9k |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | 100k | 215k | 290k | 341k | 44k |
Market Cap | 3.09M |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 771.81M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -50.00% |
52 Week High | 0.039 |
52 Week Low | 0.0016 |
Spread (Intraday) | 0 (0%) |
Company Name | Actavia Life Sciences Inc (CE) |
Address |
50 west liberty street reno, nevada 89501 |
Website | https:// |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions